SIU researcher and university professor of physiology, Dr. Dale “Buck” Buchanan, is a founding member of the Center for Cannabis Science. “We started the Cannabis Science Center in December 2018. In December 2018, it was removed from the controlled substance list and legalized for industrial-assisted use nationwide,” Buchanan said of his SIU. said in an interview with the university newspaper. Daily Egyptian“There has been an amazing explosion since then.”
Buchanan explained that he has been interested in cannabis’ cancer treatment potential since the 2018 Farm Bill passed. “The majority of ovarian cancer research is focused on prolonging what we call ‘progression-free survival,'” he added. It seems misguided to me that it’s in gradual increase…so we’re really interested in prevention.”
Rodents are the easiest subjects to study, but Buchanan notes similarities between chickens and ovarian cancer. “But chickens are counterintuitive. They get the same ovarian cancer as women. is the number of lifetime ovulations.”
His observations show that omega-3 acids contain natural anti-inflammatory proteins that help heal the scar tissue that occurs during ovulation, ultimately reducing the growth of cancerous tissue. “This resulted in a 70% reduction in cancer severity and a 30% reduction in incidence. All we did was introduce flax into their diet,” he said. “But we know nothing about how it works, so that’s our job.”
This discovery prompted researchers such as graduate student Didas Roy to investigate how the body’s endocannabinoid system, specifically receptor 1, functions. “In the endocannabinoid system, our bodies produce cannabinoids … and they bind to specific receptors 1 and 2,” Roy said. Although not expressed, receptor 1 is abundant, and cancer appears to have increased expression of these receptors.”
More specifically, Roy’s current focus is on the transforming growth factor-β (TGF-β) protein present in the ovary and the endocannabinoid system. “We know that TGF-β is also involved in cancer, so we want to know how they are related, who controls whom, and how they contribute to ovarian cancer. “TGF-β is a family of so many receptors and ligands that we’re trying to look at them all.”
according to American Cancer SocietyApproximately 19,880 women will be diagnosed with ovarian cancer in their lifetime. [in 2022], about 12,810 women die from this condition. More research is being conducted to further explore how cannabis can reduce suffering and potentially save lives. In August 2019, a survey found that CBD effectiveness For the treatment of low-grade ovarian cancer.of September 2022one study found that cannabis’ anticancer properties helped patients fight ovarian cancer and chemoresistance.
There are also growing resources of research identifying cannabis as a beneficial treatment for many types of cancer. One of his studies, published in August 2022, shows how cannabis users are less likely to develop common liver cancer, or hepatocellular carcinoma (HCC), affects about 25,000 men and 11,000 women in the United States each year (and kills about 19,000 men and 9,000 women each year). Another study shows how cannabis can benefit cancer patients by treating pain and reducing dependence on opiates. 923,000 dead As of 2020 in the United States.